Human Immunodefeciency Virus Associated Cryptococcal Meningitis At A Tertiary Care Centre: Diagnostic Tools And Antifungal Susceptibility Testing

Cryptococcal meningitis has emerged as a leading cause of the infectious morbidity and mortality in HIV sero-reactive subjects and it is the second most common cause of the opportunistic neuroinfections in it. As this is a indistinguishable from other causes of meningitis, its early diagnosis is the...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical and diagnostic research Vol. 7; no. 8; pp. 1623 - 1625
Main Author Munivenkataswamy, Rashmi
Format Journal Article
LanguageEnglish
Published India JCDR Research and Publications (P) Limited 01.08.2013
JCDR Research and Publications Private Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cryptococcal meningitis has emerged as a leading cause of the infectious morbidity and mortality in HIV sero-reactive subjects and it is the second most common cause of the opportunistic neuroinfections in it. As this is a indistinguishable from other causes of meningitis, its early diagnosis is the key to the therapeutic success. This study was undertaken to know the incidence of Cryptococcal meningitis in HIV sero-reactive individuals and to assess the role of the microbiological parameters in its specific diagnosis, with a perspective of evaluating the anti-fungal resistance. A total of 66 CSF samples from suspected cases of meningoencephalitis were subjected to standard microbiological procedures. The Cryptococcal isolates were identified by microscopy, the cultural characteristics, melanin production on Niger Seed agar, urea hydrolysis, the Nitrate assimilation test and by capsular antigen detection by latex agglutination. The Cryptoccal isolates were further biotyped by using Canavanine-Glycine-Bromothymol blue agar. The Minimum Inhibitory Concentrations (MIC) of Amphotericin B and Fluconazole for the isolates were detected. The incidence of Cryptococcal meningitis in our study group was 18.2% (12/66). The Cryptococcal antigen was detected in all the 12 cases, whereas microscopy was positive only in 9 cases and Cryptococcus was isolated by culture in 10 cases. All the isolates were sensitive to Amphotericin B and 90% of the isolates were sensitive to Fluconazole. The CD4counts ranged between 22-138 cells /μl. A high incidence of Cryptococcal meningitis in HIV sero-reactive subjects necessitates the importance of a precise and an early microbiological diagnosis for better management of such subjects. Due to the growing concern of emerging drug resistance, the testing for the anti-fungal susceptibility has to be encouraged in all the cases.
AbstractList Cryptococcal meningitis has emerged as a leading cause of the infectious morbidity and mortality in HIV sero-reactive subjects and it is the second most common cause of the opportunistic neuroinfections in it. As this is a indistinguishable from other causes of meningitis, its early diagnosis is the key to the therapeutic success.CONTEXTCryptococcal meningitis has emerged as a leading cause of the infectious morbidity and mortality in HIV sero-reactive subjects and it is the second most common cause of the opportunistic neuroinfections in it. As this is a indistinguishable from other causes of meningitis, its early diagnosis is the key to the therapeutic success.This study was undertaken to know the incidence of Cryptococcal meningitis in HIV sero-reactive individuals and to assess the role of the microbiological parameters in its specific diagnosis, with a perspective of evaluating the anti-fungal resistance.OBJECTIVESThis study was undertaken to know the incidence of Cryptococcal meningitis in HIV sero-reactive individuals and to assess the role of the microbiological parameters in its specific diagnosis, with a perspective of evaluating the anti-fungal resistance.A total of 66 CSF samples from suspected cases of meningoencephalitis were subjected to standard microbiological procedures. The Cryptococcal isolates were identified by microscopy, the cultural characteristics, melanin production on Niger Seed agar, urea hydrolysis, the Nitrate assimilation test and by capsular antigen detection by latex agglutination. The Cryptoccal isolates were further biotyped by using Canavanine-Glycine-Bromothymol blue agar. The Minimum Inhibitory Concentrations (MIC) of Amphotericin B and Fluconazole for the isolates were detected.MATERIAL AND METHODSA total of 66 CSF samples from suspected cases of meningoencephalitis were subjected to standard microbiological procedures. The Cryptococcal isolates were identified by microscopy, the cultural characteristics, melanin production on Niger Seed agar, urea hydrolysis, the Nitrate assimilation test and by capsular antigen detection by latex agglutination. The Cryptoccal isolates were further biotyped by using Canavanine-Glycine-Bromothymol blue agar. The Minimum Inhibitory Concentrations (MIC) of Amphotericin B and Fluconazole for the isolates were detected.The incidence of Cryptococcal meningitis in our study group was 18.2% (12/66). The Cryptococcal antigen was detected in all the 12 cases, whereas microscopy was positive only in 9 cases and Cryptococcus was isolated by culture in 10 cases. All the isolates were sensitive to Amphotericin B and 90% of the isolates were sensitive to Fluconazole. The CD4counts ranged between 22-138 cells /μl.RESULTSThe incidence of Cryptococcal meningitis in our study group was 18.2% (12/66). The Cryptococcal antigen was detected in all the 12 cases, whereas microscopy was positive only in 9 cases and Cryptococcus was isolated by culture in 10 cases. All the isolates were sensitive to Amphotericin B and 90% of the isolates were sensitive to Fluconazole. The CD4counts ranged between 22-138 cells /μl.A high incidence of Cryptococcal meningitis in HIV sero-reactive subjects necessitates the importance of a precise and an early microbiological diagnosis for better management of such subjects. Due to the growing concern of emerging drug resistance, the testing for the anti-fungal susceptibility has to be encouraged in all the cases.CONCLUSIONA high incidence of Cryptococcal meningitis in HIV sero-reactive subjects necessitates the importance of a precise and an early microbiological diagnosis for better management of such subjects. Due to the growing concern of emerging drug resistance, the testing for the anti-fungal susceptibility has to be encouraged in all the cases.
Cryptococcal meningitis has emerged as a leading cause of the infectious morbidity and mortality in HIV sero-reactive subjects and it is the second most common cause of the opportunistic neuroinfections in it. As this is a indistinguishable from other causes of meningitis, its early diagnosis is the key to the therapeutic success. This study was undertaken to know the incidence of Cryptococcal meningitis in HIV sero-reactive individuals and to assess the role of the microbiological parameters in its specific diagnosis, with a perspective of evaluating the anti-fungal resistance. A total of 66 CSF samples from suspected cases of meningoencephalitis were subjected to standard microbiological procedures. The Cryptococcal isolates were identified by microscopy, the cultural characteristics, melanin production on Niger Seed agar, urea hydrolysis, the Nitrate assimilation test and by capsular antigen detection by latex agglutination. The Cryptoccal isolates were further biotyped by using Canavanine-Glycine-Bromothymol blue agar. The Minimum Inhibitory Concentrations (MIC) of Amphotericin B and Fluconazole for the isolates were detected. The incidence of Cryptococcal meningitis in our study group was 18.2% (12/66). The Cryptococcal antigen was detected in all the 12 cases, whereas microscopy was positive only in 9 cases and Cryptococcus was isolated by culture in 10 cases. All the isolates were sensitive to Amphotericin B and 90% of the isolates were sensitive to Fluconazole. The CD4counts ranged between 22-138 cells /μl. A high incidence of Cryptococcal meningitis in HIV sero-reactive subjects necessitates the importance of a precise and an early microbiological diagnosis for better management of such subjects. Due to the growing concern of emerging drug resistance, the testing for the anti-fungal susceptibility has to be encouraged in all the cases.
Context: Cryptococcal meningitis has emerged as a leading cause of the infectious morbidity and mortality in HIV seroreactive subjects and it is the second most common cause of the opportunistic neuroinfections in it. As this is a indistinguishable from other causes of meningitis, its early diagnosis is the key to the therapeutic success. Objectives: This study was undertaken to know the incidence of Cryptococcal meningitis in HIV sero–reactive individuals and to assess the role of the microbiological parameters in its specific diagnosis, with a perspective of evaluating the anti–fungal resistance. Material and Methods: A total of 66 CSF samples from suspected cases of meningoencephalitis were subjected to standard microbiological procedures. The Cryptococcal isolates were identified by microscopy, the cultural characteristics, melanin production on Niger Seed agar, urea hydrolysis, the Nitrate assimilation test and by capsular antigen detection by latex agglutination. The Cryptoccal isolates were further biotyped by using Canavanine–Glycine–Bromothymol blue agar. The Minimum Inhibitory Concentrations (MIC) of Amphotericin B and Fluconazole for the isolates were detected. Results: The incidence of Cryptococcal meningitis in our study group was 18.2% (12/66). The Cryptococcal antigen was detected in all the 12 cases, whereas microscopy was positive only in 9 cases and Cryptococcus was isolated by culture in 10 cases. All the isolates were sensitive to Amphotericin B and 90% of the isolates were sensitive to Fluconazole. The CD4 counts ranged between 22-138 cells /µl. Conclusion: A high incidence of Cryptococcal meningitis in HIV sero-reactive subjects necessitates the importance of a precise and an early microbiological diagnosis for better management of such subjects. Due to the growing concern of emerging drug resistance, the testing for the anti–fungal susceptibility has to be encouraged in all the cases.
Context: Cryptococcal meningitis has emerged as a leading cause of the infectious morbidity and mortality in HIV sero-reactive subjects and it is the second most common cause of the opportunistic neuroinfections in it. As this is a indistinguishable from other causes of meningitis, its early diagnosis is the key to the therapeutic success. Objectives: This study was undertaken to know the incidence of Cryptococcal meningitis in HIV sero–reactive individuals and to assess the role of the microbiological parameters in its specific diagnosis, with a perspective of evaluating the anti–fungal resistance. Material and Methods: A total of 66 CSF samples from suspected cases of meningoencephalitis were subjected to standard microbiological procedures. The Cryptococcal isolates were identified by microscopy, the cultural characteristics, melanin production on Niger Seed agar, urea hydrolysis, the Nitrate assimilation test and by capsular antigen detection by latex agglutination. The Cryptoccal isolates were further biotyped by using Canavanine–Glycine–Bromothymol blue agar. The Minimum Inhibitory Concentrations (MIC) of Amphotericin B and Fluconazole for the isolates were detected. Results: The incidence of Cryptococcal meningitis in our study group was 18.2% (12/66). The Cryptococcal antigen was detected in all the 12 cases, whereas microscopy was positive only in 9 cases and Cryptococcus was isolated by culture in 10 cases. All the isolates were sensitive to Amphotericin B and 90% of the isolates were sensitive to Fluconazole. The CD4counts ranged between 22-138 cells /μl. Conclusion: A high incidence of Cryptococcal meningitis in HIV sero-reactive subjects necessitates the importance of a precise and an early microbiological diagnosis for better management of such subjects. Due to the growing concern of emerging drug resistance, the testing for the anti–fungal susceptibility has to be encouraged in all the cases.
Author Munivenkataswamy, Rashmi
AuthorAffiliation 1 Consultant, Department of Microbiologist, Gokula Metro Polis Diagnostics , Bangalore, India
2 Associate Professor, Department of Microbiology, KIMS Hospital and Research Centre , Bangalore, India
4 Professor, Department of Microbiology, KIMS Hospital and Research Centre , Bangalore, India
3 Post Graduate, Department of Microbiology, KIMS Hospital and Research Centre , Bangalore, India
AuthorAffiliation_xml – name: 3 Post Graduate, Department of Microbiology, KIMS Hospital and Research Centre , Bangalore, India
– name: 1 Consultant, Department of Microbiologist, Gokula Metro Polis Diagnostics , Bangalore, India
– name: 4 Professor, Department of Microbiology, KIMS Hospital and Research Centre , Bangalore, India
– name: 2 Associate Professor, Department of Microbiology, KIMS Hospital and Research Centre , Bangalore, India
Author_xml – sequence: 1
  givenname: Rashmi
  surname: Munivenkataswamy
  fullname: Munivenkataswamy, Rashmi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24086857$$D View this record in MEDLINE/PubMed
BookMark eNpVktFuFCEUhompsdvqE5gYLr3ZLgwMzHhh0kzVrqkx0dX0jjDMmZFmBlZgTPYxfGMZtzb2gpDAl4-cn_8MnTjvAKGXlFzISpDNx-bqy6YglG0E5fKCFZI-QStSS7aWpL49Qaui4PVaVsXtKTqL8Y4QIQQTz9BpwUklqlKu0O_redIOb6dpdr6DHowFZw74uw1zxJcxemN1gg434bBP3nhj9Ig_gbNusMlmJOFLvIOQrA4H3OgAuAGXArzBV1YPzsdkDd55P2bWdXkl289uyJavczSwT7a1o02HLMmoG56jp70eI7y438_Rt_fvds31-ubzh21zebM2vKBpTSkpRdFR1pV121Yg-rrWkgGRstYlK1kFlaGS14wL3prSEAZUttIQLXJoLTtH26O38_pO7YOd8gDKa6v-HvgwKJ2nMiOojpRcszJH3WnONG-7gvRCtJQA5aZfXG-Prv3cTtCZJQA9PpI-vnH2hxr8L8Xy79SUZ8Hre0HwP-cchJpsDmcctQM_R0U5Z6wqKC8z-ur_tx4e-fenGWBHwAQfY4D-AaFELc1RS3PU0hy1NEctzWF_AK-tuLU
ContentType Journal Article
Copyright 2013 Journal of Clinical and Diagnostic Research 2013
Copyright_xml – notice: 2013 Journal of Clinical and Diagnostic Research 2013
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.7860/JCDR/2013/6147.3271
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 0973-709X
EndPage 1625
ExternalDocumentID oai_doaj_org_article_d054a35013da43a4bd20f66b10e14cfb
PMC3782914
24086857
10_7860_JCDR_2013_6147_3271
Genre Journal Article
GroupedDBID ---
2WC
5VS
AAYXX
ABDBF
ACUHS
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BCNDV
CITATION
DIK
E3Z
EBD
EOJEC
ESX
GROUPED_DOAJ
GX1
HYE
KQ8
M~E
OBODZ
OK1
P6G
RNS
RPM
TR2
TUS
~8M
NPM
7X8
5PM
ID FETCH-LOGICAL-c421t-110562d13d59bb8e6f99a73e0779a53538e8c17493464bc5c03e17b7c0a6201b3
IEDL.DBID DOA
ISSN 2249-782X
IngestDate Wed Aug 27 01:07:16 EDT 2025
Thu Aug 21 18:18:43 EDT 2025
Fri Jul 11 04:11:50 EDT 2025
Thu Jan 02 22:36:53 EST 2025
Tue Jul 01 01:23:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Latex agglutination
Cryptococcal meningitis
Human Immunodefeciency Virus
Minimum inhibitory concentration
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c421t-110562d13d59bb8e6f99a73e0779a53538e8c17493464bc5c03e17b7c0a6201b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/d054a35013da43a4bd20f66b10e14cfb
PMID 24086857
PQID 1443382145
PQPubID 23479
PageCount 3
ParticipantIDs doaj_primary_oai_doaj_org_article_d054a35013da43a4bd20f66b10e14cfb
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3782914
proquest_miscellaneous_1443382145
pubmed_primary_24086857
crossref_primary_10_7860_JCDR_2013_6147_3271
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-08-01
PublicationDateYYYYMMDD 2013-08-01
PublicationDate_xml – month: 08
  year: 2013
  text: 2013-08-01
  day: 01
PublicationDecade 2010
PublicationPlace India
PublicationPlace_xml – name: India
– name: Delhi, India
PublicationTitle Journal of clinical and diagnostic research
PublicationTitleAlternate J Clin Diagn Res
PublicationYear 2013
Publisher JCDR Research and Publications (P) Limited
JCDR Research and Publications Private Limited
Publisher_xml – name: JCDR Research and Publications (P) Limited
– name: JCDR Research and Publications Private Limited
SSID ssj0066636
Score 1.9190853
Snippet Cryptococcal meningitis has emerged as a leading cause of the infectious morbidity and mortality in HIV sero-reactive subjects and it is the second most common...
Context: Cryptococcal meningitis has emerged as a leading cause of the infectious morbidity and mortality in HIV sero-reactive subjects and it is the second...
Context: Cryptococcal meningitis has emerged as a leading cause of the infectious morbidity and mortality in HIV seroreactive subjects and it is the second...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1623
SubjectTerms cryptococcal meningitis
human immunodefeciency virus
latex agglutination
minimum inhibitory concentration
Original
Title Human Immunodefeciency Virus Associated Cryptococcal Meningitis At A Tertiary Care Centre: Diagnostic Tools And Antifungal Susceptibility Testing
URI https://www.ncbi.nlm.nih.gov/pubmed/24086857
https://www.proquest.com/docview/1443382145
https://pubmed.ncbi.nlm.nih.gov/PMC3782914
https://doaj.org/article/d054a35013da43a4bd20f66b10e14cfb
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2grYzEkbBx7NhJb-2WUiotB9iivUV-TMRKKKk22cP-DP5xZ5zdqouQuHDJIYkSa77xPOzPM4y9z3SorIWQGgF5qsBXqcW4OLWNaEpvXAYNHRSefdWX1-pqUSzutfoiTthYHngU3CRgTGFp90sGq6RVLuRZo7UTGQjlG0fWF33eLpkabTDG5LE5IPqnKkUfuBjrDZlSZ5Or6fk3TPmFnKBnMh9lbsSeT4ql-_8Wb_5Jm7znhy6esMfbAJKfjgN_yh5A-4w9nG23yJ-z33FZnn-hcx9dQBnEybvhP5ardc93aEDg09XmZujQHiJKfAZj56Jlz-3ALZ8T3dquNpzOJ_G4BAwn_Hzk5eGf-bzrfuG7beCnRDdCk4Ff-b7uI0smEm43-JGeSNUv2PXFp_n0Mt32XUi9ysWQYkSAUVFAiReVcyXopqqskZAZU9lCoomE0mMmU0mllfOFzyQI44zPrEbBOvmSHbRdC6-JONU0oSkhQFAKcxenc49BkTUgg_ClTtiHneTrm7G8Ro1pCQFVE1A1AVUTUDUBlbAzQufuVaqNHW-gxtRbjan_pTEJe7fDtsa5RBsktoVu3WMapDBjp9rtCXs1Yn33KyoFp8vCJMzsacHeWPaftMufsV63RA2shHrzPwb_lj3KY0MOoiAesoNhtYYjDIsGdxxnAF4_L8QtQaUNEQ
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+Immunodefeciency+Virus+Associated+Cryptococcal+Meningitis+At+A+Tertiary+Care+Centre%3A+Diagnostic+Tools+And+Antifungal+Susceptibility+Testing&rft.jtitle=Journal+of+clinical+and+diagnostic+research&rft.au=Munivenkataswamy%2C+Rashmi&rft.date=2013-08-01&rft.issn=2249-782X&rft_id=info:doi/10.7860%2FJCDR%2F2013%2F6147.3271&rft.externalDBID=n%2Fa&rft.externalDocID=10_7860_JCDR_2013_6147_3271
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2249-782X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2249-782X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2249-782X&client=summon